Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban vs DAPT in Acute Non-disabling Cerebrovascular Events
NCT01924325Phase 3Unknown
- Sponsor
- Xijing Hospital
- Start
- Jan 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of apixaban in ischemic stroke, Transient Ischemic Attack (TIA), sponsored by Xijing Hospital. Status: unknown.
02
Drugs
apixaban
03
Conditions
ischemic strokeTransient Ischemic Attack (TIA)
Beyond the preview
Go deeper on NCT01924325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01924325.